Non-cryopreserved peripheral blood stem cells autotransplants for hematological malignancies can be performed entirely on an outpatient basis
Authors:
- 1 July 1998
- journal article
- clinical trial
- Published by Wiley in American Journal of Hematology
- Vol. 58 (3) , 161-164
Abstract
We have prospectively performed peripheral blood stem cell autotransplants in six patients with hematological malignancies on an entirely outpatient basis. Patients were conditioned with high‐dose melphalan and received a median of 4.2 × 108/kg non‐cryopreserved, non‐purged mononuclear cells, containing a median of 3.9 × 106/kg CD34 + cells. The median time to achieve > 500 granulocytes/μl was 21 days, with a range of 16 to 40, whereas the median time to achieve > 20,000 platelets/μl was 38 days, with a range of 21 to 48. Only three patients were transfused with platelets whereas packed red blood cells were transfused in two. All patients survived 60 days after the autograft and three are alive at 450, 690, and 1,950 days after the autotransplant. One patient was given an allogeneic bone marrow transplant when relapsing after the autotransplant. One patient had to be admitted to the hospital on day +10 because of fever. A median of 6,500.00 USD per patient was calculated as the total cost of each outpatient autotransplant. Since outpatient autologous transplants with non‐frozen PBSC are feasible, restrictions to PBSC autotransplant programs may be overcome and costs may be diminished. Am. J. Hematol. 58:161–164, 1998.Keywords
This publication has 14 references indexed in Scilit:
- Peripheral Blood Stem Cell and Bone Marrow Transplantation for Solid Tumors and Lymphomas: Hematologic Recovery and Costs: A Randomized, Controlled TrialAnnals of Internal Medicine, 1997
- Peripheral Blood Progenitor Cell Transplantation: A Replacement for Marrow Auto‐ or AllograftsStem Cells, 1996
- Selective discharge of patients with acute myeloid leukemia during chemotherapy-induced neutropeniaAmerican Journal of Hematology, 1996
- ATRA‐Induced gingival infiltration: Report of a caseAmerican Journal of Hematology, 1995
- Filgrastim‐mobilized peripheral‐blood stem cells can be stored at 4 degrees and used in autografts to rescue high‐dose chemotherapyAmerican Journal of Hematology, 1995
- Future outlook for growth factorsAnti-Cancer Drugs, 1993
- Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapyThe Lancet, 1992
- Hematopoietic reconstitution after high-dose chemotherapy and autologous nonfrozen bone marrow rescueAnnals of Hematology, 1991
- Autologous bone marrow transplantation for high-grade lymphoid malignancy using melphalan/irradiation conditioning without marrow purging or cryopreservation. The Northern Regional Bone Marrow Transplant GroupBlood, 1991
- Autologous peripheral hematopoietic stem cell transplantation restores hematopoietic function following marrow ablative therapyBlood, 1988